Skip to content

Clinical study of skin-beautifying effect of SkinCera supplementation.

A Prospective, Randomized, Single blind, Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of SkinCera in improving skin health.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/12/016661
Enrollment
50
Registered
2018-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: SKINCERA: Gluco ceramide 50 mg twice daily before breakfast and before dinner orally. Duration of treatment - 6 weeks Control Intervention1: Placebo: Malto-Dextrin 50 mg twice daily bef

Sponsors

Vidya Herbs Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subject who is willing and is able to comply with all trial requirements. Subjects who have some signs and symptoms related to skin cosmetic appearance such as roughness, dryness, oily skin, itching, redness, acne marks, white heads and black heads. Subjects who have hyperpigmentation problems with skin darkening and wrinkle appearance Subjects with atopic dermatitis.

Exclusion criteria

Exclusion criteria: Subjects with chronic disorders. Population containing children and geriatric individuals. Pregnant women and nursing mothers. Subjects who have the habit of smoking and drinking alcohol. Subjects who are undergoing other cosmetic treatment.

Design outcomes

Primary

MeasureTime frame
Efficacy of IP in improving skin health (mainly moisturising effect and reducing the wrinkles including atopic dermatitis).Timepoint: Week 2, 4, 6 and follow up at week 8

Secondary

MeasureTime frame
Assessment of any untoward adverse events.Timepoint: Week 2, 4, 6 and follow up at week 8

Countries

India

Contacts

Public ContactDr B N Satish

Sri Kalabyraveshwara Swamy Ayurvedic Medical College and Hospital and Research Centre

drbnsatish@yahoo.com7892914197

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 19, 2026